EQS-Adhoc: Marinomed Biotech AG: Court opens restructuring proceedings without self-administration

EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Insolvency/Restructure of Company
Marinomed Biotech AG: Court opens restructuring proceedings without self-administration

14-Aug-2024 / 15:35 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Korneuburg, Austria, 14. August 2024 – Marinomed Biotech AG (VSE:MARI) announces that on August 14, 2024, the Regional Court of Korneuburg opened restructuring proceedings without self-administration at the request of Marinomed Biotech AG. The Company expects trading of Marinomed shares to resume soon and a switch to the standard market continuous on the Vienna Stock Exchange.

+++ End of ad-hoc announcement +++

End of Inside Information

14-Aug-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com

Language: English Company: Marinomed Biotech AG Hovengasse 25 2100 Korneuburg Austria Phone: +43 2262 90300 E-mail: office@marinomed.com Internet: www.marinomed.com ISIN: ATMARINOMED6 WKN: A2N9MM Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Official Market) EQS News ID: 1968247
End of Announcement EQS News Service

1968247 14-Aug-2024 CET/CEST